Form 8-K - Current report:
SEC Accession No. 0001683168-22-005634
Filing Date
2022-08-12
Accepted
2022-08-12 16:15:54
Documents
12
Period of Report
2022-08-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio_8k.htm   iXBRL 8-K 34605
  Complete submission text file 0001683168-22-005634.txt   207032

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phio-20220809.xsd EX-101.SCH 2965
3 XBRL LABEL FILE phio-20220809_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE phio-20220809_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT phio_8k_htm.xml XML 3602
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 221160268
SIC: 2834 Pharmaceutical Preparations